4//SEC Filing
Foster-Cheek Kaye I 4
Accession 0001628280-25-029770
CIK 0001894562other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 6:13 PM ET
Size
433.7 KB
Accession
0001628280-25-029770
Insider Transaction Report
Form 4
Foster-Cheek Kaye I
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-04+55,000→ 55,000 totalExercise: $1.32Exp: 2035-06-04→ Common Stock (55,000 underlying)
Footnotes (1)
- [F1]The shares subject to this option shall vest in full upon the earlier of (i) June 4, 2026 or (ii) the date of the next annual meeting of stockholders, subject to the Reporting Person's continuous service to the Issuer through such vesting date.
Issuer
Prime Medicine, Inc.
CIK 0001894562
Entity typeother
Related Parties
1- filerCIK 0001312622
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 6:13 PM ET
- Size
- 433.7 KB